Medicine Notices




18 OCTOBER 2007 NEW ZEALAND GAZETTE, No. 112

2999

Product:
Seretide Accuhaler
Active Ingredients:
Fluticasone propionate 100µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France

Product:
Seretide Accuhaler
Active Ingredients:
Fluticasone propionate 250µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France

Product:
Seretide Accuhaler
Active Ingredients:
Fluticasone propionate 500µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France

Product:
Seretide
Active Ingredients:
Fluticasone propionate 20mg equivalent to 125µg/dose
Salmeterol xinafoate 5.8mg equivalent to 25µg/dose salmeterol
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France

Product:
Seretide
Active Ingredients:
Fluticasone propionate 40mg equivalent to 250µg/dose
Salmeterol xinafoate 5.8mg equivalent to 25µg/dose salmeterol
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France

Product:
Seretide
Active Ingredients:
Fluticasone propionate 8mg equivalent to 50µg/dose
Salmeterol xinafoate 5.8mg equivalent to 25µg/dose salmeterol
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France

Dated this 12th day of October 2007.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7230

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule
Product:
Apo-Lisinopril
Active Ingredient:
Lisinopril dihydrate 10.89mg equivalent to Lisinopril 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Lupin Limited, Verna, Salcette, Goa, India



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 112


Gazette.govt.nz PDF NZ Gazette 2007, No 112





✨ LLM interpretation of page content

🏥 Consent to Distribution of Seretide Accuhaler (100µg Fluticasone, 50µg Salmeterol)

🏥 Health & Social Welfare
12 October 2007
Medicine, Seretide Accuhaler, Fluticasone propionate, Salmeterol xinafoate, Powder for inhalation, GlaxoSmithKline
  • Anthony Hill, Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Consent to Distribution of Seretide Accuhaler (250µg Fluticasone, 50µg Salmeterol)

🏥 Health & Social Welfare
12 October 2007
Medicine, Seretide Accuhaler, Fluticasone propionate, Salmeterol xinafoate, Powder for inhalation, GlaxoSmithKline
  • Anthony Hill, Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Consent to Distribution of Seretide Accuhaler (500µg Fluticasone, 50µg Salmeterol)

🏥 Health & Social Welfare
12 October 2007
Medicine, Seretide Accuhaler, Fluticasone propionate, Salmeterol xinafoate, Powder for inhalation, GlaxoSmithKline
  • Anthony Hill, Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Consent to Distribution of Seretide (125µg Fluticasone, 25µg Salmeterol)

🏥 Health & Social Welfare
12 October 2007
Medicine, Seretide, Fluticasone propionate, Salmeterol xinafoate, Aerosol inhaler, GlaxoSmithKline
  • Anthony Hill, Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Consent to Distribution of Seretide (250µg Fluticasone, 25µg Salmeterol)

🏥 Health & Social Welfare
12 October 2007
Medicine, Seretide, Fluticasone propionate, Salmeterol xinafoate, Aerosol inhaler, GlaxoSmithKline
  • Anthony Hill, Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Consent to Distribution of Seretide (50µg Fluticasone, 25µg Salmeterol)

🏥 Health & Social Welfare
12 October 2007
Medicine, Seretide, Fluticasone propionate, Salmeterol xinafoate, Aerosol inhaler, GlaxoSmithKline
  • Anthony Hill, Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Consent to Distribution of Apo-Lisinopril

🏥 Health & Social Welfare
Medicine, Apo-Lisinopril, Lisinopril dihydrate, Tablet, Apotex
  • Minister of Health